MarketPeel
Insider Trading Intelligence
Pricing
…
DM

David Mcmullin

ALDX
CHIEF COMMERCIAL OFFICER · ALDEYRA THERAPEUTICS, INC. · CIK 0001738662
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
250,000
AVG SELL PX
—
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for David Mcmullin. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
ALDX · 250,000 shares · as of Mar 2, 2020
064,426128,852193,277257,703SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 4 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
247,480——247,480Mar 2, 2020Mar 4, 2020 ↗View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
247,480——255,183Mar 2, 2020Mar 6, 2020 ↗View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000——257,703Mar 2, 2020Mar 4, 2020 ↗View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Mar 2, 2020Mar 6, 2020 ↗View →
Other insiders · ALDX
Loading peer insiders…
About this filer
CIK 0001738662
ROLE
Chief Commercial Officer
PRIMARY
ALDX
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001738662DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback